Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Surface Plasmon Resonance (SPR) Biosensor Assay from US Patent US20240208970: "SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE"
Assay data:15 Active, 15 Activity ≤ 1 µM, 16 Tested
SummaryRelated BioAssays by Target
SARS-CoV-2 Mpro Protease Enzyme Assay from US Patent US20240208970: "SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE"
Assay data:76 Active, 51 Activity ≤ 1 µM, 79 Tested
SPR Binding Assay from US Patent US20240166598: "COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME"
Assay data:70 Active, 29 Activity ≤ 1 µM, 93 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
SARS-CoV-2, SARS-CoV-1, MERS, 0C43 and 229E Mpro Biochemical Protease Activity Assay from US Patent US20240158368: "Pyrrolidine Main Protease Inhibitors as Antiviral Agents"
Assay data:85 Active, 71 Activity ≤ 1 nM, 85 Activity ≤ 1 µM, 85 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Enzyme Assay (Cruzain) from US Patent US20240150396: "INHIBITORS OF CYSTEINE PROTEASES"
Assay data:35 Active, 2 Activity ≤ 1 nM, 27 Activity ≤ 1 µM, 36 Tested
Enzymatic Assay for Mpro from US Patent US20240131036: "COMPOSITIONS AND METHODS OF TREATING CONDITIONS"
Assay data:7 Active, 3 Activity ≤ 1 µM, 7 Tested
Mpro In Vitro Screening Assay from US Patent US11963959: "Inhibitors for coronavirus"
Assay data:12 Active, 9 Activity ≤ 1 µM, 12 Tested
SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET) from US Patent US11912714: "Spiropyrrolidine derived antiviral agents"
Assay data:47 Active, 48 Activity ≤ 1 µM, 48 Tested
Measuring Antiviral Effect of Compounds from US Patent US11905306: "Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus"
Assay data:70 Active, 38 Activity ≤ 1 µM, 80 Tested
Antiviral Assay from US Patent US20240043417: "COMPOUNDS FOR THE TREATMENT OF SARS"
Assay data:1 Active, 19 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Target
SARS-CoV-2 3CLpro Enzyme Assay from US Patent US20240043417: "COMPOUNDS FOR THE TREATMENT OF SARS"
Assay data:11 Active, 23 Tested
Antiviral Assay from US Patent US20240034730: "PYRAZOLO DERIVATIVES AS HUMAN DIHYDROOROTATE DEHYDROGENASE (HDHODH) INHIBITORS FOR USE AS ANTIVIRALS"
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
SARS-CoV-2 Plaque Assay 2 from US Patent US20240033256: "INHIBITORS OF POSITIVE STRAND RNA VIRUSES"
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SARS-CoV-2 Plaque Assay 1 from US Patent US20240033256: "INHIBITORS OF POSITIVE STRAND RNA VIRUSES"
SARS-CoV-2 Immunofluorescence Assay 2 from US Patent US20240033256: "INHIBITORS OF POSITIVE STRAND RNA VIRUSES"
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
SARS-CoV-2 Immunofluorescence Assay 1 from US Patent US20240033256: "INHIBITORS OF POSITIVE STRAND RNA VIRUSES"
Inhibition of SARS-CoV-2 3CL-Pro proteolytic cleavage of a dual-labeled substrate by FRET at 1mM DTT.
Assay data:24 Active, 19 Activity ≤ 1 µM, 64 Tested
Inhibition of SARS-CoV-2 3CL-Pro proteolytic cleavage of a dual-labeled substrate by FRET.
Assay data:33 Active, 20 Activity ≤ 1 µM, 64 Tested
Inhibition of recombinant SARS-CoV-2 main protease using Dabcyl-KTSAVLQSGFRKM-E(Edans-NH2) as substrate preincubated for 15 mins followed by substrate addition by FRET analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of recombinant SARS-CoV-2 main protease expressed in Escherichia coli BL21 using Dabcyl-EDANS and Boc-Abu-Tle-Leu-Gln-AMC as substrate
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on